Streetbeat News

Regulatory

BTC

BTC Digital has regained compliance with Nasdaq's minimum bid price requirement. The company was previously at risk of being delisted due to its share price falling below the minimum requirement.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 12:45 pm

JAGX

Napo Pharmaceuticals, a subsidiary of Jaguar Health (NASDAQ:JAGX), has submitted a grant application to the National Institute of Allergy and Infectious Diseases (NIAID) for funding to support its Phase I study of NP-300, a novel drug candidate for the treatment of moderate-to-severe diarrhea, including cholera.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 12:44 pm

ABBV

AbbVie has announced positive topline results from its Phase 3 SEQUENCE trial of Skyrizi (Risankizumab) versus Stelara (Ustekinumab). The study met its primary endpoint in patients with moderately to severely active Crohn's disease who have failed one or more anti-TNFs.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 12:34 pm

VTGN

Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company, announced that PH80, one of its investigational neuroactive nasal sprays, showed statistically significant improvement versus placebo in a Phase 2A study for acute management of the symptoms of premenstrual dysphoric disorder (PMDD).

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 12:33 pm

CLSD

Clearside Biomedical has been granted U.S. Patent #11752101 for an ocular injector and methods for accessing the suprachoroidal space of the eye. This could potentially lead to new treatments and procedures in ophthalmology.

Portfolio Pulse from Charles Gross

September 12, 2023 | 12:20 pm

INDA

India's Consumer Price Index (CPI) for August was reported at 6.83%, lower than the estimated 7% and the prior figure of 7.44%.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 12:19 pm

INFN

Infinera has announced a suite of ICE-X Coherent Pluggables and Compound Semiconductor Components to comply with Buy America requirements. This move is expected to boost the company's market position in the US.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 12:19 pm

USO

OPEC has maintained its 2024 non-OPEC supply-growth forecast at 1.4 million barrels per day (B/D), while increasing its 2023 non-OPEC supply-growth forecast by 100,000 B/D to 1.6 million B/D.

Portfolio Pulse from Bill Haddad

September 12, 2023 | 12:18 pm

USO

The Organization of the Petroleum Exporting Countries (OPEC) has maintained its global economic growth forecast at 2.6% for 2024 and 2.7% for 2023.

Portfolio Pulse from Bill Haddad

September 12, 2023 | 12:17 pm

NRXS

NeurAxis (NRXS) has announced the publication of a prospective study showing that its product, IB-Stim, improves the quality of life of adolescents with Irritable Bowel Syndrome (IBS).

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 12:15 pm